Senate panel advances legislation capping private insurance insulin at $35

The Senate Health, Education, Labor and Pensions Committee advanced bipartisan legislation capping private insurance insulin costs at $35. The measure cleared the committee by a 17-5 vote with six Republicans joining all Democrats.